Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD

This study has been completed.
Sponsor:
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00711724
First received: July 3, 2008
Last updated: June 21, 2010
Last verified: June 2010

July 3, 2008
June 21, 2010
July 2007
March 2009   (final data collection date for primary outcome measure)
The ADHD-RS and ASRS v1.1 Symptom Checklist scales [ Time Frame: Weeks 1, 2, 3, 4, 5, 6, 7, or 8 ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00711724 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD
Comparison of Self and Clinician Administered Rating Scales in Patients With Attention Deficit Hyperactivity Disorder (ADHD)

The primary objective is to establish the concurrent validity of the clinician administered Attention Deficit Hyperactivity Disorder-Rating Scale (ADHD-RS) and the patient administered Attention Deficit Hyperactivity Disorder Self Report Scale (ASRS) v1.1 Symptom Checklist.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Adolescents diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) who are enrolled in the study Protocol 2003-P-001313: "Prevention of Cigarette Smoking in ADHD Youth with CONCERTA."

Attention-Deficit/Hyperactivity Disorder (ADHD)
Not Provided
MGH 1
Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
March 2009
March 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of ADHD
  • Age 13-65* *Parental consent and patient's assent will be obtained for minors participating in this protocol (only adolescents aged 13-18 yrs old will be included in the MGH site)

Exclusion Criteria:

  • Inability to reliably report ADHD symptoms at the discretion of the investigator
Both
13 Years to 18 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00711724
2007-P-000911
No
Paul Hammerness, MD, Massachusetts General Hospital
Massachusetts General Hospital
Not Provided
Principal Investigator: Paul Hammerness, MD Massachusetts General Hospital
Massachusetts General Hospital
June 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP